Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-07-06

FDA Approved: GRISEOFULVIN — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved the original application for Griseofulvin as a generic oral antifungal indicated for dermatophyte infections such as tinea capitis, tinea corporis,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Griseofulvin (GRISEOFULVIN)

Snippet

ORIG AP for GRISEOFULVIN (GRISEOFULVIN)